Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266

Watchlist Manager
Suzhou Zelgen Biopharmaceuticals Co Ltd Logo
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Watchlist
Price: 67.99 CNY -0.89% Market Closed
Market Cap: 18B CNY
Have any thoughts about
Suzhou Zelgen Biopharmaceuticals Co Ltd?
Write Note

Suzhou Zelgen Biopharmaceuticals Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Suzhou Zelgen Biopharmaceuticals Co Ltd
Other Operating Expenses Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Suzhou Zelgen Biopharmaceuticals Co Ltd
SSE:688266
Other Operating Expenses
ÂĄ74.2m
CAGR 3-Years
50%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other Operating Expenses
ÂĄ210.1m
CAGR 3-Years
12%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Operating Expenses
ÂĄ45.2m
CAGR 3-Years
-7%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other Operating Expenses
ÂĄ20m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Operating Expenses
-ÂĄ96.3m
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
-8%
Imeik Technology Development Co Ltd
SZSE:300896
Other Operating Expenses
ÂĄ25.6m
CAGR 3-Years
147%
CAGR 5-Years
72%
CAGR 10-Years
N/A

See Also

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Other Operating Expenses?
Other Operating Expenses
74.2m CNY

Based on the financial report for Dec 31, 2023, Suzhou Zelgen Biopharmaceuticals Co Ltd's Other Operating Expenses amounts to 74.2m CNY.

What is Suzhou Zelgen Biopharmaceuticals Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
35%

Over the last year, the Other Operating Expenses growth was 183%. The average annual Other Operating Expenses growth rates for Suzhou Zelgen Biopharmaceuticals Co Ltd have been 50% over the past three years , 35% over the past five years .

Back to Top